Shukra Pharmaceuticals Gains 2.36%: Key Milestones and Market Momentum in November
2026-11-21 17:05:19Key Events This Week 16 Nov: Stock opens at Rs.82.24, marginally down 17 Nov: Slight uptick to Rs.82.25 amid steady volumes 18 Nov: Minor dip to Rs.82.23 on heavy volume 19 Nov: Small decline to Rs.82.22 despite Sensex rebound 20 Nov: New 52-week and all-time high at Rs.85.07, closes at Rs.84.19 (+2.40%) Week OpenRs.82.25 <div...
Read More
Broad-Based Technical Strength Lifts Shukra Pharmaceuticals Ltd to 52-Week High of Rs 85.07
2026-11-20 14:05:15With a remarkable ascent from Rs 26.30 to Rs 85.07 over the past year, Shukra Pharmaceuticals Ltd has more than doubled its share price, culminating in a fresh 52-week high on 20 Nov 2026. This milestone reflects a powerful confluence of technical momentum and sustained earnings growth that has propelled the stock well ahead of the broader market.
Read More
Shukra Pharmaceuticals Ltd Surges to All-Time High of Rs 84.32 on Strong Momentum
2026-11-20 13:51:53Extending its remarkable rally, Shukra Pharmaceuticals Ltd touched a fresh all-time high of Rs 84.32 on 20 Nov 2026, continuing its outperformance against the broader market and its sector peers.
Read More
Shukra Pharmaceuticals Ltd is Rated Buy
2026-11-17 10:10:50Shukra Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 22 September 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 17 November 2026, providing investors with the latest insights into its performance and outlook.
Read MoreShukra Pharmaceuticals Gains 2.85%: 4 Key Factors Driving the Week’s Momentum
2026-11-14 17:02:35Key Events This Week 09 Nov: New 52-week high at Rs.84.55 and all-time high near Rs.83.64 13 Nov: New 52-week and all-time high at Rs.84.73 13 Nov: Stock closes at Rs.82.25, up 0.09% on the day Week OpenRs.79.97 Week CloseRs.82.25+2.85% <div cl...
Read More
Broad-Based Technical Strength Lifts Shukra Pharmaceuticals Ltd to 52-Week High of Rs 84.73
2026-11-13 11:10:08Surging nearly 98% over the past year from a low of Rs 26.30, Shukra Pharmaceuticals Ltd has reached a fresh 52-week high of Rs 84.73 on 13 Nov 2026, propelled by a confluence of strong technical signals and sustained earnings momentum.
Read More
Shukra Pharmaceuticals Ltd Hits All-Time High of Rs 84.73 as Momentum Builds Across Timeframes
2026-11-13 11:07:05Extending its remarkable rally, Shukra Pharmaceuticals Ltd touched a fresh all-time high of Rs 84.73 on 13 Nov 2026, outperforming the broader Sensex which declined by 0.30% on the same day. This milestone caps a sustained period of strong gains, with the stock surging over 100% in the past three months and nearly doubling in the last year.
Read More
Broad-Based Technical Strength Lifts Shukra Pharmaceuticals Ltd to 52-Week High of Rs 84.55
2026-11-09 09:40:58Surging past Rs 84.55 on 09 Nov 2026, Shukra Pharmaceuticals Ltd has achieved a remarkable 52-week high, marking a doubling in its share price from the low of Rs 26.30 recorded last year. This milestone is underpinned by a confluence of robust technical indicators and sustained price momentum, setting the stock apart in the Pharmaceuticals & Biotechnology sector.
Read More
Strong Momentum Meets Stretched Valuations as Shukra Pharmaceuticals Ltd Reaches All-Time High
2026-11-09 09:32:27Extending a four-day winning streak, Shukra Pharmaceuticals Ltd surged 2.61% on 9 Nov 2026 to close near its 52-week high at Rs 83.64, marking a fresh all-time peak for the micro-cap pharmaceutical player. This advance outpaced the Sensex, which slipped 0.14% on the day, underscoring the stock’s robust momentum amid a mixed broader market backdrop.
Read MoreAnnouncement under Regulation 30 (LODR)-Change of Company Name
16-Nov-2026 | Source : BSEApproval for Change of Name of Company on National Stock Exchange Limited dated 16th November 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
06-Nov-2026 | Source : BSENewspaper Publication of Quarterly Results
Announcement under Regulation 30 (LODR)-Press Release / Media Release
05-Nov-2026 | Source : BSEMedia Release
Corporate Actions
No Upcoming Board Meetings
Shukra Pharmaceuticals Ltd has declared 1% dividend, ex-date: 21 Sep 26
Shukra Pharmaceuticals Ltd has announced 1:10 stock split, ex-date: 21 Mar 25
Shukra Pharmaceuticals Ltd has announced 3:1 bonus issue, ex-date: 19 Apr 24
Shukra Pharmaceuticals Ltd has announced 6:1 rights issue, ex-date: 02 Feb 23